Levolin Nebulizer Solution Dosing Guidelines
Dosing Recommendations
- The American Academy of Allergy, Asthma, and Immunology recommends a dose of 0.075 mg/kg (minimum dose 1.25 mg) of Levolin nebulizer solution for children, administered every 20 minutes for the first 3 doses, then every 1-4 hours as needed, up to a maximum of 5 mg per dose 1
- For children aged 3-11 years with acute asthma exacerbations, the initial dose is 0.075 mg/kg (minimum dose 1.25 mg) via nebulizer 1
- For children under 12 years old, 0.25 mg nebulized every 20 minutes for up to 3 doses is recommended, according to the British Thoracic Society 2
- For children 12 years and older, 0.5 mg nebulized every 20 minutes for up to 3 doses is recommended, according to the British Thoracic Society 2
Administration Guidelines
- The British Thoracic Society recommends that Levosalbutamol nebulizer solution should be delivered via oxygen-driven nebulizer when possible, especially in acute severe asthma 2, 1
- A gas flow of 6-8 L/min with a minimum dilution of 3 mL should be used for optimal delivery, as suggested by the American Academy of Allergy, Asthma, and Immunology 1
- The solution can be mixed with ipratropium bromide for nebulization in cases of severe asthma, according to the British Thoracic Society 2
Special Situations
- For severe or life-threatening asthma exacerbations, the American Academy of Allergy, Asthma, and Immunology recommends considering more frequent administration (up to every 20 minutes) 1
- In severe cases, combining with ipratropium bromide (250 μg every 20 minutes for 3 doses) is recommended by the American Academy of Allergy, Asthma, and Immunology 1
- For patients with brittle asthma who develop sudden severe attacks, a higher dose of 5 mg may be required, according to the British Thoracic Society 2
Alternative Treatment Options
- For regular treatment at home, the American Academy of Allergy, Asthma, and Immunology suggests considering alternative delivery methods such as metered dose inhaler with spacer before resorting to nebulizer therapy 1